Clinical Trial: Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Metastatic Colorectal Cancer
Study Type: INTERVENTIONAL
Official Title: Phase II Study of Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
Brief Summary:
This study is being done to see if combining liposomal irinotecan with TAS102 and bevacizumab confers clinical benefit for patients with treatment refractory metastatic colorectal cancer.
Read more